In contrast to serum IGF-1, IGF-1R activity, especially cytoplasmic and nuclear IGF-1R expression, has been proven to promote radiotherapy resistance and enhance the risk of biological cancer recurrence [41]. The gene discussed is IGF1R; the disease is cancer.